Table 2.
Thoracic lymphadenopathies on MDCT characteristics at initial assessment
| Characteristics | Total |
|---|---|
| (N = 23) | |
| Total number of thoracic LAP | 79 |
| Per patient in median (IQR) (max–min) | 3 (2–5) (1–8) |
| 1 (%) | 5 (21.7) |
| 2 (%) | 4 (17.4) |
| 3 (%) | 3 (13.0) |
| 4 (%) | 5 (21.7) |
| 5 (%) | 2 (8.7) |
| 6 (%) | 2 (8.7) |
| 7 (%) | 1 (4.4) |
| 8 (%) | 1 (4.4) |
| Thoracic LAP > 2 (%) | 14 (60.9) |
| Size in mean ± SD (max – min) | 11.7 ± 1.7 (10–18) |
| Localization* | |
| 1R (%) | 1 (1.3) |
| 1L (%) | 1 (1.3) |
| 2R (%) | 3 (3.8) |
| 2L (%) | 1 (1.3) |
| 3 (%) | 1 (1.3) |
| 4R (%) | 18 (22.7) |
| 4L (%) | 3 (3.8) |
| 5 (%) | 4 (5.0) |
| 6 (%) | 4 (5.0) |
| 7 (%) | 12 (15.2) |
| 8 (%) | 2 (2.5) |
| 9 (%) | 0 (0) |
| 10R (%) | 16 (20.3) |
| 10L (%) | 13 (16.5) |
| Calcification (%) | 6 (12.5) |
LAP = lymphadenopathie; CT = computed-tomodensitometry
*Localization according to the chest cartography of the American Thoracic Society (20)